Cegedim (ALCGM.PA) Stock Price
Cegedim Price
Over the last 19 years Cegedim grew revenue by 1.0% annually, reaching 649.17 M EUR. Earnings per share have declined at 7.2% per year over the last 19 years. For Cegedim, the net margin of 1.4% is down versus 5.0% a few years ago. At today's price the dividend yield works out to roughly 4.63%. The payout ratio is around 50% of earnings. The consensus 12-month price target for Cegedim is 13.26 EUR, about 22.8% above where the stock trades today. Of 9 analysts, 0 rate the stock a buy — an overall Sell consensus.
Cegedim stock price
Cegedim business model & stock analysis
Frequently asked questions about Cegedim
Cegedim SA is a global technology and services company serving the healthcare industry. Its business model revolves around providing innovative solutions and services to healthcare professionals, pharmaceutical companies, and other stakeholders. Cegedim SA offers a wide range of products, including patient data management systems, electronic health records, pharmacy management software, and marketing solutions. Through its comprehensive portfolio, Cegedim SA enables better patient care, drives operational efficiency, and facilitates collaboration within the healthcare ecosystem. With years of expertise and a strong focus on technology-driven solutions, Cegedim SA continues to play a crucial role in transforming and improving healthcare worldwide.
Cegedim SA is primarily active in the healthcare and technology industries.
The main competitors of Cegedim SA in the market include IBM, Cerner Corporation, and Allscripts Healthcare Solutions.
Cegedim SA, a leading technology and services company, has a rich history and background. Established in 1969, Cegedim initially focused on providing innovative software solutions for healthcare professionals. Over the years, it expanded its offerings to pharmaceutical companies, insurance providers, and other healthcare stakeholders. Today, Cegedim is a global organization, operating in over 70 countries and serving more than 420,000 users. The company's strong commitment to research and development has allowed it to stay at the forefront of digital transformation in the healthcare industry. Cegedim SA's expertise and comprehensive portfolio make it a trusted partner for businesses seeking innovative and efficient healthcare solutions.
Cegedim SA, a renowned company, has achieved several significant milestones throughout its existence. It has successfully positioned itself as a global leader in innovative technology and services for the healthcare industry. Over the years, Cegedim SA has shown exceptional growth and development, expanding its presence across multiple continents. The company has established fruitful partnerships with key industry players and consistently delivers cutting-edge solutions to optimize healthcare practices. Cegedim SA's dedication to excellence and commitment to meeting evolving market demands have propelled them to become a trusted and respected name in the healthcare sector.
Cegedim SA is primarily present in various countries and regions worldwide. With its headquarters in France, the company has established a strong presence in Europe, particularly in countries like Germany, Italy, Spain, and the United Kingdom. Additionally, Cegedim SA operates in North America, with a significant presence in the United States and Canada. Furthermore, the company has expanded its reach to other regions, including Asia Pacific and Latin America. This global presence allows Cegedim SA to cater to a diverse range of clients and leverage its expertise in healthcare and technology solutions on an international scale.
Cegedim SA represents a set of core values and a strong corporate philosophy. The company is committed to excellence, innovation, and client satisfaction. With a focus on technological advancements and healthcare solutions, Cegedim SA strives to provide cutting-edge products and services. They prioritize integrity, transparency, and collaboration, aiming to build strong, trust-based relationships with their clients and partners. Cegedim SA's dedication to continuous improvement and customer-centricity drives their success in the dynamic stock market. This French-based company's values and philosophy define their approach to business and reinforce their position as a leading player in the industry.
Analysts currently set an average price target of 12.92 EUR for the Cegedim stock (median: 13.26 EUR), implying +19.6 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Cegedim stock: 0 recommend buying, 5 holding and 4 selling. For 2026, analysts expect Cegedim to generate revenue of 660.10 M EUR and earnings per share of 1.21 EUR.
The Cegedim share (ALCGM.PA) is listed on 7 stock exchanges, including: London (0DYQ.L), Frankfurt (C7E.F), München (C7E.MU), Düsseldorf (C7E.DU), Paris (CGM.PA).
Cegedim SA is a leading company in the healthcare industry that offers innovative technologies and services for medical record management, insurance claims processing, and the pharmaceutical industry. The company operates in various sectors, including Cegedim Health Data, Cegedim e-business, Cegedim Insurance Solutions, and Cegedim Strategic Data. Cegedim Health Data provides specialized solutions for managing medical patient data and interoperability within the healthcare industry. Cegedim e-business offers electronic transaction services and software platforms for businesses in the healthcare industry. Cegedim Insurance Solutions provides high-quality IT services for the health and accident insurance industry. Cegedim Strategic Data specializes in collecting and processing market data for the pharmaceutical and healthcare industries. In addition to these business sectors, Cegedim SA also offers specialized products and solutions. Their business model is focused on supporting healthcare industry customers to work efficiently and effectively by providing them with technology and data solutions.
The expected revenue of Cegedim is 660.10 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cegedim is 16.64 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cegedim is currently 8.94. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cegedim stock.
The price-to-sales ratio (P/S) of Cegedim is currently 0.23. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cegedim stock.
The Eulerpool Quality Score for Cegedim is 2/10.
The ISIN of Cegedim is FR0000053506. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Cegedim is 895036. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Cegedim is ALCGM.PA. The ticker symbol is used to trade Cegedim shares on the stock exchange.
Cegedim stock
Cegedim Peer Group
Cegedim Ticker
Cegedim FIGI
All fundamentals and in-depth analysis of Cegedim
Our stock analysis for Cegedim stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cegedim. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.